Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
via HealthDayTUESDAY, June 2, 2026 — A smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.
The SUPPORT+ app asks them each week to complete a short questionnaire about their physical and emotional symptoms, researchers reported at a meeting of the American Society for Clinical Oncology (ASCO) in Chicago.
Patients using the app had better quality of life than those receiving usual care, who had to take it upon themselves to proactively report any new or worsening symptoms, researchers said.
“This randomized clinical trial demonstrates that proactively monitoring symptoms using a digital platform, combined with timely nurse follow-up, can help maintain quality of life and reduce unplanned hospitalizations,” said lead researcher Dr. Wendy Wing-lok Chan, a clinical associate professor of oncology at the University of Hong Kong in China.
For the study, researchers recruited more than 1,200 people with advanced cancer who were not being actively treated for cancer. They came from six palliative care clinics in Hong Kong.
Roughly half were assigned to use the SUPPORT+ app, in which they provided a weekly self-assessment of their symptoms.
The app itself provided practical guidance on managing mild or moderate symptoms. More severe or worsening symptoms were referred to a team of palliative care nurses for review, with a nurse reaching out by phone to provide support.
After 18 weeks, about 12% people in the app group experienced a decline in their level of functioning, compared with more than 17% in the usual care group, researchers found.
Overall quality-of-life scores actually increased after 18 weeks among app users, but declined for those with usual care.
The number of ER visits was similar between the two groups, but app users had fewer hospital admissions and shorter hospital stays.
“People with cancer frequently suffer from symptoms such as pain, fatigue or sleep disturbance and often bear those symptoms silently. When patients are able to report symptoms and receive help, they feel better, and that can lead to better outcomes,” said Dr. Toby Christopher Campbell, who reviewed the findings. He’s a thoracic medical oncologist and health chief of palliative care at the University of Wisconsin in Madison.
“This trial adds to the evidence base that patients, with high-quality reporting and interventions, can improve their symptoms and their quality of life,” he added in a news release. “As the trial uses a mobile app for symptom monitoring, patients need to be savvy enough to interact with an app and implement the instructions given.”
Researchers presented their findings Sunday at ASCO’s meeting in Chicago.
The study was also published June 1 in JAMA Network Open.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-06-02 23:14
Read more
- Head Impacts May Disrupt Gut Health Even Without Concussion
- FDA Blocked Melanoma Drug As Confusion Reigned Under Makary
- Somatic Symptoms Tied to Depression With Ovarian Cancer
- FDA Approves AI Sepsis Tool That Detects Infection Hours Earlier Than Doctors
- argenx Announces U.S. FDA Approval Expanding Vyvgart and Vyvgart Hytrulo for Use in All Adult Patients Living with gMG
- 50 Large TB Outbreaks Identified in 23 States During 2017 to 2023
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions